A Study of V330 in Healthy Younger (18 to 49 Years Inclusive) and Healthy Older (60 to 79 Years Inclusive) Participants (V330-001)

PHASE1RecruitingINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

July 23, 2026

Study Completion Date

January 25, 2027

Conditions
Healthy
Interventions
BIOLOGICAL

V330

Intramuscular injection

BIOLOGICAL

Placebo

Intramuscular injection

Trial Locations (4)

33009

RECRUITING

Velocity Clinical Research, Hallandale Beach ( Site 0003), Hallandale

33024

RECRUITING

Research Centers of America ( Hollywood ) ( Site 0004), Hollywood

33143

RECRUITING

QPS-MRA, LLC-Early Phase ( Site 0006), South Miami

91206

RECRUITING

California Clinical Trials Medical Group managed by PAREXEL ( Site 0002), Glendale

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY